Belgium-based Sunrise, a health-tech company that claims to be revolutionizing sleep analysis, announced that it has raised €17M in a fresh round of funding.
This funding is in addition to €12M that the startup has already raised since its inception.
The startup plans to accelerate its growth in commercializing its technology in the US and recruiting new talent. Sunrise wants to increase the number of teams it has by 10 over the next five years.
The current round was led by Kurma Partners and saw the entry of the European Innovation Council (EIC Fund), the European Commission’s renowned deeptech initiative.
Founded in 2015 by Laurent Martinot and Pierre Martinot, Sunrise believes everyone should have a sleep test at least once in their lives. That’s why the startup is reimagining sleep apnoea detection.
Sunrise detects respiratory events based on the analysis of the trigeminal drive.
This new technology measures movement caused by the contraction of respiratory muscles and provides reliable and accurate information to analyze sleep.
Sunrise has already reached a major milestone in its global development with the FDA’s acceptance of its second-generation technology in America and the European Union’s recent Medical Device Regulation (MDR) clearance of its second-generation technology.
The startup claims to have grown significantly in recent months.
The Sunrise team consists of 30 people and has around 20 vacancies in Belgium, France, and the US. It intends to grow further in the coming months.
Read more on Tech Gist Africa:
Belgium-based Cumul.io secures €10M
Belgium-based Vertuoza has secured €4M in a Pre-Series A round